News - Endovascular Today
WEB5 days ago · Jupiter Endovascular Receives IDE Approval for SPIRARE II Pivotal Trial. September 10, 2024—Jupiter Endovascular, Inc., announced recently that the FDA has approved the company’s application for an investigational device exemption (IDE) for the SPIRARE II pivotal study in the United States. Sep 10 2024.
Endovascular Today
WEBPhilips’ LumiGuide Enhanced 160-cm Endovascular Navigation Wire Gains FDA Approval. September 17, 2024—Royal Philips announced the introduction of the FDA-approved, 160-cm version of its LumiGuide endovascular navigation wire, which uses the company’s Fiber Optic RealShape (FORS) technology. Sep 16 2024.
Iliac Vein Stenting: Best Practices for Patient Safety and Successful ...
WEBFor a chronically occluded vein, stent sizing can be based on known normal diameters of iliac veins: 14 to 16 mm for the CIV, 12 to 14 mm for the external iliac vein (EIV), and 10 to 12 mm for the CFV. 19 The length of stent (s) needed is determined most efficiently by the IVUS catheter, which has radiopaque markers.
US Device Guide - Endovascular Today
WEBThis Device Guide offers a comprehensive listing of the available vascular interventional devices in the United States. The charts include sizes, configurations, and unique characteristics of each product, listed alphabetically by manufacturer name. Our annual Device Guide is updated throughout the year and represents the most current listings.
CT Venography: Technique and Indications - Endovascular Today
WEBCT Venography: Technique and Indications. A brief summary of how to perform indirect and direct CT venography and when this imaging modality can be helpful in diagnosing venous disease. By Ana Marija Alduk, MD, PhD, and Gerard O'Sullivan, MD. CT venography (CTV) is not a particularly well-validated technique, with most data derived from ...
Stryker’s Target Tetra Detachable Coil for Treating Small …
WEBDecember 15, 2022—Stryker announced FDA 510(k) clearance of the Target Tetra detachable coil, the latest addition to the company’s Target platform.
Percutaneous Deep Venous Arterialization - Endovascular Today
WEBPercutaneous Deep Venous Arterialization. A brief technical overview of a new therapy for treating end-stage “no-option” critical limb ischemia. Critical limb ischemia (CLI) has far-reaching implications in terms of quality of life and survival, as well as socioeconomic consequences. The patient’s desire for a minimally invasive approach ...
European Device Guide - Endovascular Today
WEBThis Device Guide offers a comprehensive listing of the available vascular interventional devices in the European market. The charts include sizes, configurations, and unique characteristics of each product, listed alphabetically by manufacturer name. Our annual Device Guide is updated throughout the year and represent the most current listings.
The Right Device in Right Heart: AngioVac System for Clot in …
WEBThe last decade has seen significant improvement in the use of minimally invasive technologies for the removal of undesirable intravascular materials such as deep vein thrombus, clot in transit, and right heart masses to reduce the occurrence of pulmonary emboli, and in case of endocarditis, to eliminate a source of ongoing sepsis. 1-4 With no defined treatment algorithm, surgical embolectomy ...
EVAR Versus the Endoleak - Endovascular Today
WEBIt is the EVAR (and us) versus the endoleak. Despite its early advantage, EVAR is associated with a higher rate of late (8 years) rupture compared with open repair (5.4% vs 1.4%). 1 Some of the key contributors to this failure are endoleaks. The approach to endoleak management has varied over time. Early in the application of EVAR, an ...
Skip to content